Redmile Group’s Lifestance Health LFST Stock Holding History

Redmile Group’s Portfolio LFST Stock Details LFST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,222,408	Closed	-$17.7M	–	74
2021 Q3	$17.7M	Sell	1,222,408 -34,659	-3%	-$667K	0.31%	57
2021 Q2	$35M	Buy	+1,257,067	New	+$33.2M	0.52%	50

Other funds holding LFST

TGA

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

Summit Partners Boston, Massachusetts $670M AUM 6.71% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Redmile Group's LFST Position: Q4 2021 in Review

Redmile Group sold out of Lifestance Health (LFST) in Q4 2021, closing a stake of 1,222,408 shares — an estimated $17.7M sold.

Redmile Group first reported a position in LFST in Q2 2021 and held it in 2 quarters. The position peaked at $35M in Q2 2021. 66 funds tracked by Wall St. Rank hold LFST as of Q4 2021.

Redmile Group reported no remaining Lifestance Health position as of Q4 2021 after selling out during the quarter.
Redmile Group sold 1,222,408 Lifestance Health shares in Q4 2021, an estimated $17.7M.
Redmile Group first reported a position in Lifestance Health in Q2 2021 and held it in 2 quarters.
Redmile Group's Lifestance Health position peaked at $35M in Q2 2021.
66 funds tracked by Wall St. Rank held Lifestance Health as of Q4 2021.

Based on Redmile Group's 13F filing for Q4 2021, filed 14 Feb 2022.